Industry: Medical Devices & Consumables
Published Date: 2025-03-10
Pages: 94 Pages
Report ld: 4608485
Request Sample
Customized Report
Muscle-on-a-Chip Market Size(US$)

CAGR 2025-2031
26.1%
Market Size,2031
USD 1,445
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Muscle-on-a-Chip was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 1445 million by 2031, growing at a CAGR of 26.1% during the forecast period.
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
As an emerging market segment in the biomedical field, the muscle chip market has gradually attracted widespread attention from the industry in recent years. Muscle chips can simulate the structure and function of muscle tissue, providing a powerful tool for the research of muscle-related diseases, drug development and personalized medicine. Muscle chips have broad application potential in multiple fields, including diagnosis of muscle diseases, drug screening, toxicity testing, sports rehabilitation, and personalized medicine. By simulating the physiological and pathological processes of muscle tissue, muscle chips can help researchers gain a deeper understanding of the pathogenesis of muscle diseases, accelerate drug development, and improve treatment effects. Overall, the muscle chip market has broad development prospects and huge market potential.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Muscle-on-a-Chip, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Muscle-on-a-Chip.
The Muscle-on-a-Chip market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Muscle-on-a-Chip market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Muscle-on-a-Chip manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Emulate
CN Bio
TissUse
Axion Biosystems
Nortis
BioIVT
InSphero
Mimetas
Ascendance Biotechnology
StemoniX
Tara Biosystems
BGI Genomics
Segment by Type
Skeletal Muscle
Smooth Muscle
Other
Segment by Application
Pharmaceutical R&D
Sports Medicine
Sports Equipment Development
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Muscle-on-a-Chip manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Muscle-on-a-Chip in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Muscle-on-a-Chip Market Overview
1.1 Product Definition
1.2 Muscle-on-a-Chip by Type
1.2.1 Global Muscle-on-a-Chip Market Value Comparison by Type (2024 VS 2031)
1.2.2 Skeletal Muscle
1.2.3 Smooth Muscle
1.2.4 Other
1.3 Muscle-on-a-Chip by Application
1.3.1 Global Muscle-on-a-Chip Market Value by Application (2024 VS 2031)
1.3.2 Pharmaceutical R&D
1.3.3 Sports Medicine
1.3.4 Sports Equipment Development
1.4 Global Muscle-on-a-Chip Market Size Estimates and Forecasts
1.4.1 Global Muscle-on-a-Chip Revenue 2020-2031
1.4.2 Global Muscle-on-a-Chip Sales 2020-2031
1.4.3 Global Muscle-on-a-Chip Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Muscle-on-a-Chip Market Competition by Manufacturers
2.1 Global Muscle-on-a-Chip Sales Market Share by Manufacturers (2020-2025)
2.2 Global Muscle-on-a-Chip Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Muscle-on-a-Chip Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Muscle-on-a-Chip, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Muscle-on-a-Chip, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Muscle-on-a-Chip, Product Type & Application
2.7 Global Key Manufacturers of Muscle-on-a-Chip, Date of Enter into This Industry
2.8 Global Muscle-on-a-Chip Market Competitive Situation and Trends
2.8.1 Global Muscle-on-a-Chip Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Muscle-on-a-Chip Players Market Share by Revenue
2.8.3 Global Muscle-on-a-Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Muscle-on-a-Chip Market Scenario by Region
3.1 Global Muscle-on-a-Chip Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Muscle-on-a-Chip Sales by Region: 2020-2031
3.2.1 Global Muscle-on-a-Chip Sales by Region: 2020-2025
3.2.2 Global Muscle-on-a-Chip Sales by Region: 2026-2031
3.3 Global Muscle-on-a-Chip Revenue by Region: 2020-2031
3.3.1 Global Muscle-on-a-Chip Revenue by Region: 2020-2025
3.3.2 Global Muscle-on-a-Chip Revenue by Region: 2026-2031
3.4 North America Muscle-on-a-Chip Market Facts & Figures by Country
3.4.1 North America Muscle-on-a-Chip Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Muscle-on-a-Chip Sales by Country (2020-2031)
3.4.3 North America Muscle-on-a-Chip Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Muscle-on-a-Chip Market Facts & Figures by Country
3.5.1 Europe Muscle-on-a-Chip Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Muscle-on-a-Chip Sales by Country (2020-2031)
3.5.3 Europe Muscle-on-a-Chip Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Muscle-on-a-Chip Market Facts & Figures by Region
3.6.1 Asia Pacific Muscle-on-a-Chip Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Muscle-on-a-Chip Sales by Region (2020-2031)
3.6.3 Asia Pacific Muscle-on-a-Chip Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Muscle-on-a-Chip Market Facts & Figures by Country
3.7.1 Latin America Muscle-on-a-Chip Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Muscle-on-a-Chip Sales by Country (2020-2031)
3.7.3 Latin America Muscle-on-a-Chip Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Muscle-on-a-Chip Market Facts & Figures by Country
3.8.1 Middle East and Africa Muscle-on-a-Chip Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Muscle-on-a-Chip Sales by Country (2020-2031)
3.8.3 Middle East and Africa Muscle-on-a-Chip Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Muscle-on-a-Chip Sales by Type (2020-2031)
4.1.1 Global Muscle-on-a-Chip Sales by Type (2020-2025)
4.1.2 Global Muscle-on-a-Chip Sales by Type (2026-2031)
4.1.3 Global Muscle-on-a-Chip Sales Market Share by Type (2020-2031)
4.2 Global Muscle-on-a-Chip Revenue by Type (2020-2031)
4.2.1 Global Muscle-on-a-Chip Revenue by Type (2020-2025)
4.2.2 Global Muscle-on-a-Chip Revenue by Type (2026-2031)
4.2.3 Global Muscle-on-a-Chip Revenue Market Share by Type (2020-2031)
4.3 Global Muscle-on-a-Chip Price by Type (2020-2031)
5 Segment by Application
5.1 Global Muscle-on-a-Chip Sales by Application (2020-2031)
5.1.1 Global Muscle-on-a-Chip Sales by Application (2020-2025)
5.1.2 Global Muscle-on-a-Chip Sales by Application (2026-2031)
5.1.3 Global Muscle-on-a-Chip Sales Market Share by Application (2020-2031)
5.2 Global Muscle-on-a-Chip Revenue by Application (2020-2031)
5.2.1 Global Muscle-on-a-Chip Revenue by Application (2020-2025)
5.2.2 Global Muscle-on-a-Chip Revenue by Application (2026-2031)
5.2.3 Global Muscle-on-a-Chip Revenue Market Share by Application (2020-2031)
5.3 Global Muscle-on-a-Chip Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Emulate
6.1.1 Emulate Company Information
6.1.2 Emulate Description and Business Overview
6.1.3 Emulate Muscle-on-a-Chip Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Emulate Muscle-on-a-Chip Product Portfolio
6.1.5 Emulate Recent Developments/Updates
6.2 CN Bio
6.2.1 CN Bio Company Information
6.2.2 CN Bio Description and Business Overview
6.2.3 CN Bio Muscle-on-a-Chip Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CN Bio Muscle-on-a-Chip Product Portfolio
6.2.5 CN Bio Recent Developments/Updates
6.3 TissUse
6.3.1 TissUse Company Information
6.3.2 TissUse Description and Business Overview
6.3.3 TissUse Muscle-on-a-Chip Sales, Revenue and Gross Margin (2020-2025)
6.3.4 TissUse Muscle-on-a-Chip Product Portfolio
6.3.5 TissUse Recent Developments/Updates
6.4 Axion Biosystems
6.4.1 Axion Biosystems Company Information
6.4.2 Axion Biosystems Description and Business Overview
6.4.3 Axion Biosystems Muscle-on-a-Chip Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Axion Biosystems Muscle-on-a-Chip Product Portfolio
6.4.5 Axion Biosystems Recent Developments/Updates
6.5 Nortis
6.5.1 Nortis Company Information
6.5.2 Nortis Description and Business Overview
6.5.3 Nortis Muscle-on-a-Chip Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Nortis Muscle-on-a-Chip Product Portfolio
6.5.5 Nortis Recent Developments/Updates
6.6 BioIVT
6.6.1 BioIVT Company Information
6.6.2 BioIVT Description and Business Overview
6.6.3 BioIVT Muscle-on-a-Chip Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BioIVT Muscle-on-a-Chip Product Portfolio
6.6.5 BioIVT Recent Developments/Updates
6.7 InSphero
6.7.1 InSphero Company Information
6.7.2 InSphero Description and Business Overview
6.7.3 InSphero Muscle-on-a-Chip Sales, Revenue and Gross Margin (2020-2025)
6.7.4 InSphero Muscle-on-a-Chip Product Portfolio
6.7.5 InSphero Recent Developments/Updates
6.8 Mimetas
6.8.1 Mimetas Company Information
6.8.2 Mimetas Description and Business Overview
6.8.3 Mimetas Muscle-on-a-Chip Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mimetas Muscle-on-a-Chip Product Portfolio
6.8.5 Mimetas Recent Developments/Updates
6.9 Ascendance Biotechnology
6.9.1 Ascendance Biotechnology Company Information
6.9.2 Ascendance Biotechnology Description and Business Overview
6.9.3 Ascendance Biotechnology Muscle-on-a-Chip Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ascendance Biotechnology Muscle-on-a-Chip Product Portfolio
6.9.5 Ascendance Biotechnology Recent Developments/Updates
6.10 StemoniX
6.10.1 StemoniX Company Information
6.10.2 StemoniX Description and Business Overview
6.10.3 StemoniX Muscle-on-a-Chip Sales, Revenue and Gross Margin (2020-2025)
6.10.4 StemoniX Muscle-on-a-Chip Product Portfolio
6.10.5 StemoniX Recent Developments/Updates
6.11 Tara Biosystems
6.11.1 Tara Biosystems Company Information
6.11.2 Tara Biosystems Description and Business Overview
6.11.3 Tara Biosystems Muscle-on-a-Chip Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Tara Biosystems Muscle-on-a-Chip Product Portfolio
6.11.5 Tara Biosystems Recent Developments/Updates
6.12 BGI Genomics
6.12.1 BGI Genomics Company Information
6.12.2 BGI Genomics Description and Business Overview
6.12.3 BGI Genomics Muscle-on-a-Chip Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BGI Genomics Muscle-on-a-Chip Product Portfolio
6.12.5 BGI Genomics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Muscle-on-a-Chip Industry Chain Analysis
7.2 Muscle-on-a-Chip Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Muscle-on-a-Chip Production Mode & Process Analysis
7.4 Muscle-on-a-Chip Sales and Marketing
7.4.1 Muscle-on-a-Chip Sales Channels
7.4.2 Muscle-on-a-Chip Distributors
7.5 Muscle-on-a-Chip Customer Analysis
8 Muscle-on-a-Chip Market Dynamics
8.1 Muscle-on-a-Chip Industry Trends
8.2 Muscle-on-a-Chip Market Drivers
8.3 Muscle-on-a-Chip Market Challenges
8.4 Muscle-on-a-Chip Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Muscle-on-a-Chip market is projected to grow from US$ 359 million in 2025 to US$ 1784 million by 2032, at a CAGR of 26.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-31
Pages: 167
USD 4900.00
(Single User License)
The global Muscle-on-a-Chip market size was US$ 359 million in 2025 and is forecast to reach a readjusted size of US$ 1784 million by 2032 with a CAGR of 26.1% during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 92
USD 4250.00
(Single User License)
The global market for Muscle-on-a-Chip was estimated to be worth US$ 359 million in 2025 and is projected to reach US$ 1784 million, growing at a CAGR of 26.1% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 112
USD 3950.00
(Single User License)
The global Muscle-on-a-Chip market was valued at US$ 359 million in 2025 and is anticipated to reach US$ 1784 million by 2032, at a CAGR of 26.1% from 2026 to 2032.
Published Date: 2026-01-15
Pages: 124
USD 2900.00
(Single User License)
The global Muscle-on-a-Chip market is projected to grow from US$ 291 million in 2024 to US$ 1445 million by 2031, at a CAGR of 26.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 166
USD 4900.00
(Single User License)
The global Muscle-on-a-Chip market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 92
USD 4250.00
(Single User License)
The global market for Muscle-on-a-Chip was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 126
USD 3950.00
(Single User License)
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published Date: 2024-04-28
Pages: 97
USD 2900.00
(Single User License)
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published Date: 2024-04-28
Pages: 113
USD 3950.00
(Single User License)
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published Date: 2024-04-28
Pages: 122
USD 4350.00
(Single User License)
The global Muscle-on-a-Chip market is projected to grow from US$ 359 million in 2025 to US$ 1784 million by 2032, at a CAGR of 26.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-31
Pages: 167
The global Muscle-on-a-Chip market size was US$ 359 million in 2025 and is forecast to reach a readjusted size of US$ 1784 million by 2032 with a CAGR of 26.1% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 92
The global market for Muscle-on-a-Chip was estimated to be worth US$ 359 million in 2025 and is projected to reach US$ 1784 million, growing at a CAGR of 26.1% from 2026 to 2032.
Published: 2026-01-19
Pages: 112
The global Muscle-on-a-Chip market was valued at US$ 359 million in 2025 and is anticipated to reach US$ 1784 million by 2032, at a CAGR of 26.1% from 2026 to 2032.
Published: 2026-01-15
Pages: 124
The global Muscle-on-a-Chip market is projected to grow from US$ 291 million in 2024 to US$ 1445 million by 2031, at a CAGR of 26.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 166
The global Muscle-on-a-Chip market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 92
The global market for Muscle-on-a-Chip was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 126
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published: 2024-04-28
Pages: 97
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published: 2024-04-28
Pages: 113
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published: 2024-04-28
Pages: 122
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now